IntegraGen
Provides genomic services for cancer and rare diseases, translating research to practice.
ALINT | PA
Overview
Corporate Details
- ISIN(s):
- FR0010908723
- LEI:
- 969500CQD8K0BUIGDH55
- Country:
- France
- Address:
- 5 RUE HENRI DESBRUERES, 91000 EVRY-COURCOURONNES
- Website:
- https://integragen.com/
Description
IntegraGen, an OncoDNA company, specializes in translating molecular research into clinical practice, with a primary focus on cancer genomics and rare genetic diseases. The company provides comprehensive genomic services, including Next-Generation Sequencing (NGS) and advanced bioinformatics analysis, to academic researchers, biopharmaceutical companies, and clinical research organizations. Operating from a CLIA/CAP-certified laboratory, IntegraGen is a key genomics partner for oncology clinical trials. Its core mission involves identifying novel genetic biomarkers to develop and commercialize molecular diagnostic tests, delivering interpretable genomic data to advance both research and patient care.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2022-01-18 18:56 |
Acquisition ou cession des actions de l'émetteur / Information relative au cont…
|
French | 255.6 KB | ||
| 2022-01-14 07:30 |
Informations privilégiées / Information sur chiffre d’affaires annuel
|
French | 254.8 KB | ||
| 2021-10-08 07:30 |
Inside Information / News release on accounts, results
|
English | 347.0 KB | ||
| 2021-10-08 07:30 |
Informations privilégiées / Communiqué sur comptes, résultats
|
French | 310.4 KB | ||
| 2021-07-16 07:30 |
Informations privilégiées / Autres communiqués
|
French | 256.0 KB | ||
| 2021-07-16 07:30 |
Inside Information / Other news releases
|
English | 239.0 KB | ||
| 2021-07-13 17:53 |
Acquisition ou cession des actions de l'émetteur / Information relative au cont…
|
French | 229.3 KB | ||
| 2021-04-16 21:02 |
Informations privilégiées / Communiqué sur comptes, résultats
|
French | 285.7 KB | ||
| 2021-01-12 08:00 |
Informations privilégiées / Information sur chiffre d’affaires annuel
|
French | 729.6 KB | ||
| 2021-01-06 17:59 |
Acquisition ou cession des actions de l'émetteur / Information relative au cont…
|
French | 201.9 KB | ||
| 2020-11-16 19:46 |
Communiqués publiés en période d'offre publique d'acquisition / OPA Autres comm…
|
French | 200.2 KB | ||
| 2020-10-29 17:00 |
Communiqués publiés en période d'offre publique d'acquisition / OPA Autres comm…
|
French | 422.2 KB | ||
| 2020-10-29 10:39 |
Franchissement de seuils
|
French | 261.5 KB | ||
| 2020-09-18 07:30 |
Informations privilégiées / Communiqué sur comptes, résultats
|
French | 849.0 KB | ||
| 2020-09-16 07:30 |
Communiqués publiés en période d'offre publique d'acquisition / OPA Modalités d…
|
French | 390.0 KB |
Automate Your Workflow. Get a real-time feed of all IntegraGen filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for IntegraGen
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for IntegraGen via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
